<DOC>
	<DOC>NCT00000343</DOC>
	<brief_summary>The purpose of this study is to identify the neurophysiologic indicators of cocaine or methamphetamine use and withdrawal, to examine the relationship between subjects' reports of depression, craving, and stimulant use, and neurophysiologic measures, and to identify neurophysiologic measures which can be used to identify new treatments for stimulant dependence.</brief_summary>
	<brief_title>Brain Changes in Stimulant Dependent Subjects - 8</brief_title>
	<detailed_description>By Incorporating QEEG into clinical trails, the plan is to develop physiologic markers of treatment efficacy, and to aid in the identification of effective treatments.</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<criteria>M/F ages 2150. Meet DSMIV criteria for cocaine dependence. Agree to conditions of the study and sign informed consent. Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 1996</verification_date>
	<keyword>stimulant dependence</keyword>
</DOC>